Securities code: 002688 securities abbreviation: Jinhe Biotechnology Co.Ltd(002688) Announcement No.: 2022-003 Jinhe Biotechnology Co.Ltd(002688)
With regard to the suggestive announcement on the listing and circulation of non-public offering of restricted shares, the company and all personnel of the board of directors guarantee that the contents of the announcement are true, accurate and complete, and are responsible for the false records, misleading statements or major omissions in the announcement. Special tips:
1. The shares released this time are RMB ordinary shares (A shares) that are not publicly issued by Jinhe Biotechnology Co.Ltd(002688) (hereinafter referred to as “the company” and ” Jinhe Biotechnology Co.Ltd(002688) “).
2. The number of shares to be released this time is 145132743, accounting for 23.3711% of the company’s current tradable shares without sale conditions and 18.5967% of the company’s current total share capital of 780422398 shares.
3. There are 10 issuing objects applying for lifting the restrictions on the sale of shares this time, involving 61 securities accounts, and the period of restriction promised at the time of issuance is 6 months.
4. The starting date of restricted shares is August 12, 2021, and the listing and circulation date of restricted shares is February 14, 2022.
1、 Overview of the lifting of restricted shares
Approved by the reply on approving Jinhe Biotechnology Co.Ltd(002688) non-public development shares (zjxk [2020] No. 3344) issued by the China Securities Regulatory Commission, the company issued 145132743 RMB ordinary shares (A shares) to 10 specific objects in a non-public offering, with a par value of RMB 1 per share and a specific issue price of RMB 5.65 per share, The total amount of funds raised in this issuance is 81999997.95 yuan. After deducting the issuance expenses (excluding value-added tax) of 17756396.62 yuan, the net amount of funds raised is 802243601.33 yuan. The new shares in this non-public offering were listed on Shenzhen Stock Exchange on August 12, 2021. The nature of the new shares issued this time is tradable shares with limited sales conditions. The restricted sales period of the shares subscribed by the issuing object is 6 months. In case of legal holidays or rest days, it will be postponed to the first trading day thereafter. The details are as follows:
Sequence name of issuing object number of allocated shares allocated amount lock-in period (share) (yuan) (month)
1 Inner Mongolia Financial Asset Management Co., Ltd. 35398230 19999999.50 6
2 Yihe Yinfeng Tianyuan (Tianjin) Group Co., Ltd. 7079646 399999.90 6
3 Cathay Pacific Fund Management Co., Ltd. 13451327 75999997.55 6
4 Huaxia Fund Management Co., Ltd. 9734513 54999998.45 6
5 SAIC Qizhen (Shanghai) Asset Management Co., Ltd. 7079646 399999.90 6
6 China Galaxy Securities Co.Ltd(601881) 23,716,814 133,999,999.10 6
7 Guosen Securities Co.Ltd(002736) 8,849,557 49,999,997.05 6
8 Zhuang Li 12389380 69999997.00 6
9 Shanghai Bansheng Investment Management Co., Ltd. 7306194 4127996.10 6
10 CAITONG Fund Management Co., Ltd. 20127436 113720013.40 6
Total 145132743 81999997.95-
For details, the company published on cninfo.com.cn on August 10, 2021 Report on the issuance of Jinhe Biotechnology Co.Ltd(002688) non public offering shares and listing announcement. After the completion of this non-public offering, the company added 145132743 tradable shares with limited sales conditions, and the total share capital increased from 635289655 shares to 780422398 shares. After this non-public offering of shares, the company did not change its total share capital due to profit distribution, conversion of capital reserve into share capital, etc.
2、 Implementation of commitments by the issuing object applying for lifting the restrictions on the sale of shares
(I) commitments made by the issuer applying for lifting the restrictions on the sale of shares
Inner Mongolia Financial Asset Management Co., Ltd., Yihe Yinfeng Tianyuan (Tianjin) Group Co., Ltd., Cathay Pacific Fund Management Co., Ltd., Huaxia Fund Management Co., Ltd., SAIC Qizhen (Shanghai) Asset Management Co., Ltd., China Galaxy Securities Co.Ltd(601881) , Guosen Securities Co.Ltd(002736) , Zhuang Li, Shanghai Bansheng Investment Management Co., Ltd CAITONG Fund Management Co., Ltd., as the subscription object of the company’s non-public offering of shares in 2021, has made the following commitments on this subscription:
6 months from Jinhe Biotechnology Co.Ltd(002688) the closing date of this non-public offering
Within months, the above shares subscribed by the unit / myself will not be transferred.
After the expiration of the lock-in period, the reduction of the shares of the above company subscribed by the unit / myself will also comply with the company law, securities law, Shenzhen Stock Exchange Stock Listing Rules and other laws, regulations, rules, normative documents, relevant rules of Shenzhen Stock Exchange and relevant provisions of the articles of Association.
(II) performance of the above commitments
As of the disclosure date of this announcement, the issuing objects applying for lifting the restrictions on sales have strictly fulfilled the above commitments.
(III) occupation of funds of listed companies and illegal guarantee
As of the disclosure date of this announcement, none of the issuing objects applying for lifting the restrictions on the sale of shares has occupied the company’s funds for non operation, and the company has no illegal guarantee for them.
3、 The listing and circulation arrangement of restricted shares is lifted this time
1. The listing and circulation date of the restricted shares is February 14, 2022.
2. The number of restricted shares lifted this time is 145132743 shares, accounting for 18.5967% of the company’s current total share capital of 780422398 shares.
3. There are 10 issuing objects applying for lifting the restrictions on the sale of shares, involving a total of 61 securities accounts, and there is no pledge or freezing (from the data of Shenzhen Branch of China Securities Depository and Clearing Corporation Limited as of February 7, 2022). The specific circumstances of lifting the restrictions on the sale of shares are as follows:
Serial no. Name of share subscription object number of shares with limited sales number of shares (shares) released this time (shares)
1 Inner Mongolia Financial Asset Management Co., Ltd. 35398230
2 Yihe Yinfeng Tianyuan (Tianjin) Group Co., Ltd. 7079646 7079646
3 Cathay Pacific Fund Management Co., Ltd
4 Huaxia Fund Management Co., Ltd. 9734513
5 SAIC Qizhen (Shanghai) Asset Management Co., Ltd. 7079646 7079646
6 China Galaxy Securities Co.Ltd(601881) 23,716,814 23,716,814
7 Guosen Securities Co.Ltd(002736) 8,849,557 8,849,557
8 Zhuang Li 12389380 12389380
9 Shanghai Bansheng Investment Management Co., Ltd. 7306194
10 CAITONG Fund Management Co., Ltd. 20127436 20127436
Total 145132743
4. The changes of the company’s share capital structure after the lifting of share restrictions and listing and circulation of shares are shown in the following table:
Changes in the nature of the shares (+ / -) before and after this change
Number of shares (shares) proportion of restricted shares listed shares (shares) number of shares (shares) proportion
1、 Restricted sales conditions: circulating 159429424.00 20.43% – 145132743.00 14296681.00 1.83% shares / non circulating shares
Senior management locking shares 14296681.00 1.83% 14296681.00 1.83%
Restricted shares after IPO 145132743.00 18.60% – 145132743.00 —
2、 Unlimited sales conditions flow 620992974.00 79.57% 145132743.00 766125717.00 98.17% through shares
3、 Total share capital 780422398.00 100.00% 780422398.00 100.00%
Note: the share capital structure after the restrictions are lifted this time shall be subject to the final handling result of Shenzhen Branch of China Securities Depository and Clearing Co., Ltd.
5. Since the date of the listing and circulation of the restricted shares, the share restriction commitments made by the above issuing objects have been fulfilled, and they have no other commitments to the company.
4、 Verification opinions of the recommendation institution
After verification, the sponsor believes that: Jinhe Biotechnology Co.Ltd(002688) the listing and circulation of restricted shares meets the requirements of relevant laws, regulations and normative documents such as the stock listing rules of Shenzhen Stock Exchange (revised in 2022), the self regulatory guidelines for listed companies of Shenzhen Stock Exchange No. 1 – standardized operation of listed companies on the main board; The number of restricted shares lifted and the listing and circulation time of the company’s restricted shares meet the requirements of relevant laws, administrative regulations, departmental rules and relevant rules; The holders of shares whose sales restrictions have been lifted this time have strictly fulfilled the share locking commitment made during the non-public offering of shares. As of the date of issuance of the verification opinions, the company’s disclosure of relevant information about the lifting of the ban on restricted shares is true, accurate and complete. The recommendation institution has no objection to Jinhe Biotechnology Co.Ltd(002688) the listing and circulation of restricted shares in this non-public offering.
5、 Documents for future reference
1. Application form for listing and circulation of restricted shares;
2. List of share capital structure and list of restricted shares;
3. Verification opinions of Orient Securities Company Limited(600958) underwriting and recommendation Co., Ltd. on the listing and circulation of Jinhe Biotechnology Co.Ltd(002688) restricted shares of non-public development banks;
4. Application for listing and circulation of restricted shares of non-public development banks.
It is hereby announced.
Jinhe Biotechnology Co.Ltd(002688) board of directors
February 8, 2022
